Tune Therapeutics Company Profile, Contacts & Intelligence

Tune Therapeutics Overview

The vast majority of human disease is governed by the epigenome, the subtle machinery that controls the volume of gene expression in cells. Tune Therapeutics is pioneering the creation of epi-therapeutic medicines with its powerful and precise epigenomic control platform, TEMPO. Unlike genome editing, TEMPO dials the volume of gene expression up or down towards healthy levels, without breaking or permanently rewriting DNA – and it can do this in multiple genes at once. This genetic tuning approach allows us to change cell fate and function at will, unlocking the ability to reverse pathways of cancer, genetic disease and aging. Our approach effectively expands the potential reach of genetic medicine – from targeting a limited range of rare conditions, to overcoming thousands of complex and chronic diseases that currently have no curative treatment.

Headquarters

United States

Website

www.tunetx.com

Industry

Biotechnology

Founded

2020

Tune Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Tune Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Tune Therapeutics Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Tune Therapeutics

Explore companies in related markets and compare their industry and employee estimates.